Urinary Retention and Voiding Dysfunction History of Presenting Illness



Similar documents
symptoms of Incontinence

Early Prostate Cancer: Questions and Answers. Key Points

URINARY INCONTINENCE CASE PRESENTATION #1. Urinary Incontinence - History 2014/10/07. Structure of the Female Lower Urinary Tract

MANAGEMENT OF PROSTATE ENLARGEMENT/BPH

Topic review: Clinical presentation and diagnosis of urinary incontinence in the elderly. Prapa Pattrapornpisut 7 June 2012

Overactive Bladder (OAB)

150640_Brochure_B 4/12/07 2:58 PM Page 2. Patient Information. Freedom From an Enlarged Prostate

Female Urinary Disorders and Pelvic Organ Prolapse

Incontinence. What is incontinence?

Urinary Incontinence in Women. Susan Hingle, M.D. Department of Medicine

HEALTH NEWS PROSTATE CANCER THE PROSTATE

Urinary Incontinence FAQ Sheet

PSA Screening for Prostate Cancer Information for Care Providers

Normal bladder function requires a coordinated effort between the brain, spinal cord, and the bladder.

URINARY INCONTINENCE IN WOMEN

Bladder Health Promotion

Urinary Incontinence (Involuntary Loss of Urine) A Patient Guide

These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.

1 ST JAMAICAN PAEDIATRIC NEPHROLOGY CONFERENCE

FEMALE INCONTINENCE REVIEW

Prostate Specific Antigen (PSA) Blood Test

Primary Care Management of Male Lower Urinary Tract Symptoms. Matthew B.K. Shaw Consultant Urological Surgeon

Bladder Health Promotion

PATIENT GUIDE. Localized Prostate Cancer

CMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014

Medical Tests for Prostate Problems

Lower Urinary Tract Symptoms (LUTS) in Middle-Aged and Elderly Men

Bowel and Bladder Dysfunction in MS. Tracy Walker, WOCN, MSCN, FNP C Nurse Practitioner MS Institute at Shepherd Center. Bladder Dysfunction

A918: Prostate: adenocarcinoma

LCD for Prostate Specific Antigen (PSA)

Radiation Therapy for Prostate Cancer

Urinary Incontinence. Causes of Incontinence. What s Happening?

Prostate Cancer Screening. A Decision Guide

Treating Localized Prostate Cancer A Review of the Research for Adults

Refer to Coaptite Injectable Implant Instructions for Use provided with product for complete instructions for use.

Learning Resource Guide. Understanding Incontinence Prism Innovations, Inc. All Rights Reserved

Treating Prostate Cancer

Prostate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).

Prostate Cancer Screening. A Decision Guide for African Americans

Urinary Incontinence. Types

URINARY INCONTINENCE

Urinary Incontinence Dr. Leffler

Urinary Continence. Second edition FAST FACTS. by Julian Shah and Gary Leach. Anatomy and physiology 7. Investigations and diagnosis 11

Case Based Urology Learning Program

GreenLight laser prostatectomy

AFTER DIAGNOSIS: PROSTATE CANCER Understanding Your Treatment Options

Bard: Prostate Cancer Treatment. Bard: Pelvic Organ Prolapse. Prostate Cancer. An overview of. Treatment. Prolapse. Information and Answers

Overactive bladder and urgency incontinence

LOSS OF BLADDER CONTROL IS TREATABLE TAKE CONTROL AND RESTORE YOUR LIFESTYLE

Gwen Griffith Clinical Nurse Specialist Bolton NHS foundation Trust

DIAGNOSIS OF PROSTATE CANCER

Adult Urodynamics: American Urological Association (AUA)/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU) Guideline

PROSTATE ENLARGEMENT A GUIDE TO URINARY SYMPTOMS IN MEN A BOOKLET IN THE SERIES OF CONSUMER GUIDES ON MALE REPRODUCTIVE HEALTH FROM

Prostate Cancer. Patient Information

Us TOO University Presents: Understanding Diagnostic Testing

1. What is the prostate-specific antigen (PSA) test?

Prostate Cancer Action Plan: Choosing the treatment that s right for you

Overactive Bladder (OAB) Content of the lecture

A Woman s Guide to Prostate Cancer Treatment

Enlarged prostate A guide to diagnosis and treatment

CARE PROCESS STEP EXPECTATIONS RATIONALE

An illustrated guide to the management of incontinence.

Women suffer in silence

PCA3 DETECTION TEST FOR PROSTATE CANCER DO YOU KNOW YOUR RISK OF HAVING CANCER?

Prostate Cancer. Understanding your diagnosis

Fecal incontinence (Encopresis) It is the fecal incontinence condition observed in children with chronic constipation over 1-2 years.

GLOSSARY of research terms

Urinary Incontinence

Overactive bladder is a common condition thought to. women, and is a serious condition that can lead to. significant lifestyle changes.

FAQ About Prostate Cancer Treatment and SpaceOAR System

PROCEDURE FOR THE ASSESSMENT OF ADULTS AND CHILDREN WITH BLADDER OR BOWEL DYSFUNCTION

The PSA Test for Prostate Cancer Screening:

Urinary Incontinence

CONTENTS: WHAT S IN THIS BOOKLET

surg urin Surgery: Urinary System 1

Prostate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.

Urinary Incontinence Definitions

Prostate Cancer Screening. Dr. J. McCracken, Urologist

An Introduction to PROSTATE CANCER

Advanced Prostate Cancer Treatments

Acute urinary retention evaluated with urodynamic assessment in elder male W23, 16 October :00-10:30

Urinary Incontinence

Urinary Incontinence. Anatomy and Terminology Overview. Moeen Abu-Sitta, MD, FACOG, FACS

male sexual dysfunction

URINARY CATHETER CARE

Consumer summary Minimally invasive techniques for the relief of stress urinary incontinence

For further information on screening and early detection of prostate cancer, see the Section entitled Screening for Prostate Cancer.

Prostate Cancer In-Depth

Overview of Urinary Incontinence in the Long Term Care Setting

Transcription:

Urinary Retention and Voiding Dysfunction History of Presenting Illness - Urgency gotta go NOW DIFFERENTIALS: Bladder Cancer Bladder Stones Bladder Trauma Chronic Pelvic Pain Interstitial Cystitis Neurogenic Bladder Prostatitis, Bacterial Prostatitis, Tuberculous Prostatodynia Radiation Cystitis Urethral Strictures UTI put together by Alex Yartsev: Sorry if i used your images or data and forgot to reference you. Tell me who you are. aleksei.igorevich@gmail.com Leakage of urine is a problem for 65% of women over the age of 65. It affects 22% of man of the same age. - Frequency (experts disagree on how often is too often) - Nocturia (more than 3 times) - Hesitancy (cant start going) - Terminal Dribbling (cant stop going) - Weak Stream (almost diagnostic of obstruction) If they are having to perform the Valsalva manoeuvre to urinate, its very likely that the obstruction is a crude mechanical one, originating from the prostate - Strangury (small stream gets through, followed by a painful desire to urinate again) - Pis-en-Deux (the need to go again right after you have gone) - Incontinence: Stress Incontinence = loss of urine when pressure within the abdomen increases. = usually described as the involuntary loss of urine while coughing, sneezing, laughing, or = usually in women who have had several children = weakness in pelvic floor muscles is the aetiology Poor bladder support by the pelvic muscles results in the opening and descent of the urethra when abdominal pressure is increased. Types I, IIa, and IIb incontinence are progressive forms of this urethral "hypermobility." Intrinsic sphincter deficiency (Type III incontinence) is another cause of stress incontinence due to a nonfunctional proximal urethra that remains open at all times. This may be due to surgery or just getting old. Urge incontinence involves the sudden sensation of a need to urinate with inability to get to a toilet before involuntary leakage occurs. At times, urine may leak without any warning. This is due to an overactive bladder that suddenly contracts without the patient's desire for it to do so. Usually the result of ineffective descending inhibition.. Mixed incontinence is a combination of both stress and urge incontinence Overflow incontinence occurs when the bladder is so full that it leaks urine, or "overflows." This can happen when an enlargement of the prostate blocks the urethra Can also happen in situations where is bladder is too weak to contract and force the urine out, such as in diabetes or certain neurologic disorders. Environmental incontinence is when there just isnt a toilet anywhere near you, or you are just past the point of being able to use one. ASK ABOUT DRUGS: ones which affect the autonomic NS. Alpha-1 noradrenaline receptors: Pseudoephedrine can cause retention by acting as an alpha-agonist prazosin and terazosin are alpha-antagonists, reduce tone in the bladder neck so they are used to treat patients with prostatic enlargement and associated symptoms. M-3 muscarinic acetylcholine receptors; block them and the sphincter will not move Ipratropium bromide = anticholinergic bronchodilator ; will cause retention in the elderly Antidepressants also mainly dangerous only in the elderly Oxybutynin has some direct relaxant activity on smooth muscle as well as antagonising muscarinic receptors, having more potent anti-spasmodic effects than atropine in detrusor smooth muscle but possessing less anticholinergic activity than atropine. This drug is used to treat patients with " unstable " bladders which are thought to be due to increased bladder tone. Bethanechol, which is a synthetic stable analogue of acetylcholine, stimulates muscarinic receptors so it contracts the detrusor muscle and initiates micturition. It can be used to treat atonic bladders. Physical Examination - Assure yourself that there is nothing wrong with the external genitals - Look for signs of neurological damage eg. diabetic stigma - Look for scars of previous pelvic and abdominal surgery - Is there a palpable distended bladder? - IT WOULD BE CRIMINAL NOT TO DO A DIGITAL RECTAL EXAM

INVESTIGATIONS : need to rule out the scariest things first - URINALYSIS (blood with the above symptoms is bad news; may mean that a bladder cancer is growing over the urethra) - Nocturia with lots of urinary glucose may suggest diabetes - Leucocytes may indicate a UTI - Urinary Cytology: may be of use in trying to determine source of obstruction; abnormal cells will be reported. But its not as good as a proper cystoscopic biopsy. - CULTURE IT if suspecting UTI - EUC to exclude renal failure as the cause OR the consequence of urinary retention - FBC where the WCCs will be elevated in prostatitis - PSA is where the money is: it will be elevated in BPH, prostatitis, or prostate cancer- but not bladder cancer. International Prostate Symptom Score (IPSS): not quite an investigation, but an internationally validated means of seeing just how bad the problem is in terms of its effect on QOL. The score is a ratings system. Use it to gauge response to treatment. IMAGING : its all a prelude to the biopsy. BLADDER ULTRASOUND: how much are you retaining? Do we need to drain it ASAP? AFTER voluntary voiding, do it again: WHATS THE RESIDUAL VOLUME? TRANS-RECTAL ULTRA SOUND (TRUS): best prostate imaging there is Can also guide the biopsy needle CYSTOSCOPY biopsies may be taken and the bladder walls can be imaged. URODYNAMICS specialised labs run tests to dtermine the exact point at which the obstruction is, and /or what the cause of the incontinence may be. Bladder motility may be imaged in real-time using a radio-opaque dye. Not for the amateurs. IMAGING OF THE UPPER URINARY TRACT is indicated if the creatinine is high MANAGEMENT: Conservative BPH and early-stage non-invading prostate cancer can be allowed to stew. Provided the symptoms are under control it will not cause any further trouble; considering especially that the rate of growth is so slow and that most gentlemen with these problems present in their late 70s, it is unreasonable to push for surgery. ONE STUDY: Of all men followed for 10 years, 40% died of causes other than prostate cancer. This study was performed prior to PSA screening. (i.e the presentations were later) MEDICATIONS: Alpha-1-blockers: in particular Alpha-1-a Considerable component of BPH is smooth muscle proliferation; plus the bladder muscles hypertrophy and become hypertonic. To relax these means to decrease resistance to passage of urine and to improve distension of the bladder. Nonselective alpha-blockers include phenoxybenzamine. Selective short-acting alpha-1 blockers include prazosin, alfuzosin, and indoramin. Selective long-acting alpha-1 blockers include terazosin and doxazosin. Partially subtype (alpha-1a) selective agents include tamsulosin. ANDROGEN ABLATION: mainly for the already-resected cancer; Cyproterone acetate (Androcur, synthetic steroid, potent antiandrogen ) Flutamide (Eulexin), nonsteroidal, pure antiandrogens. Finasteride (Proscar, inhibitor of the 5-α-reductase enzyme that prevent the conversion of testosterone into dihydrotestosterone (DHT) which is the active form, the one the prostate cells are so excited by.

MANAGEMENT: Radical TURP: risk of morbidity (18%) and mortality (0.23%). Not to be taken lightly. This procedure is performed with regional or general anesthesia Itnvolves the placement of a working sheath in the urethra through which a hand-held device with an attached wire loop is placed. High-energy electrical cutting current is run through the loop so that the loop can be used to shave away prostate tissue. The entire device is usually attached to a video camera to provide vision for the surgeon. - A urinary catheter must be left in place until the bleeding has mostly cleared. - Also, the nerves associated with erection run along the outer rim of the prostate, and the high-energy current and/or heat generated by such may damage these nerves, resulting in impotence. - STAGING of Carcinoma of the Prostate: Gleason score: determined by the glandular architecture within the tumor. Indications for TURP: - acute urinary retention, - failed voiding trials, - recurrent gross hematuria, - urinary tract infection, - renal insufficiency secondary to obstruction 2-4 = low grade or well differentiated. 5-7 I= moderate grade or moderately differentiated. 8-10 = high grade or poorly differentiated. - The predominant pattern and the second most common pattern are given grades from 1-5. - The sum of these 2 grades is referred to as the Gleason score. - This scoring method was found to be superior for predicting disease outcomes when compared with using the individual grades alone. Grades are based on the extent to which the epithelium assumes a normal glandular structure. A grade of 1 indicates a near-normal pattern, and grade 5 indicates the absence of any glandular pattern (less malignant to more malignant). This scheme of grading histological features is highly dependent on the skill and experience of the pathologist and is subject to some degree of individual variation. MANAGEMENT revolves around PROSTATECTOMY and how many nodes to take. FOLLOWING RESECTION: - Androgen ablation is in order - External beam radiotherapy (if side-effects allow; its mainly for the high-grade tumours which were resected with positive margins) EPIDEMIOLOGY Incidence of BPH increases with age - Men aged 60 years: 50% - Men aged 80 years: 88% Incidence of symptomatic onset is related to ethnicity - African american men: onset at age 60 years - Caucasian men: onset at age 65 years Autopsies of men in the eighth decade of life show hyperplastic changes in >90% and malignant changes in >70% of individuals

MECHANISMS OF CONTINENCE AND INCONTINENCE URGE incontinence FUNCTION OF THE PROSTATE: - Controlled by testosterone: prostate epithelium and stromal cells convert it into its active form. - STROMAL CELLS are the prostate farmers, they produce growth factors and regulate secretion. They seem to be responsible for BPH when they over-stimulate themselves and their neighbouring cells. - THE PROSTATE SECRETES FLUID: 20% of ejaculated volume Exactly what this achieves is uncertain. Theoretically some components of the secretion have a buffering and antimicrobial activity which helps protect your sperm from the surface-of-venus-like environment of the vagina. - Zink, citric acid, polyamines (buffers?) - PSA (liquefactive proteinase) The seminal vesicles secrete the rest of the ejaculated volume. Their secretions are rich in fructose and this is convenient for the fructoseeating sperm, who have no mitochondria.

Molecular Mechanisms of Prostatic Carcinogenesis INCREASING LEVELS OF ANDROGENS Sensitization of of epithelial cells to DHT (?) by estrogen receptor beta; also seems to increase effect of growth factors RISK FACTORS: - Family history - BRCA-1 mutations - High androgen levels - African extraction - Fatty diet PROTECTIVE FACTORS: - Asian extraction - Selenium - Vitamin A Stromal cell Epithelial cell TESTOSTERONE Converted into DHT in both cells INCREASING LEVELS OF ESTROGEN Autocrine + Paracrine growth stimulation ENLARGEMENT of the gland: ~ 1 cubic centimetre per year Mainly in transitional zone (right over the urethra) Increased prostate cell longevity Worsening outflow obstruction; greater force required to void Hesitancy Rising PSA Reduced rate of apoptosis Breakdown of cell-cycle checkpoints, particularly reliance on androgens as growth promoters Development of Adenocarcinoma Detrusor Hypertrophy Large detrusor gets tired quickly; THUS: INCOMPLETE EMPTYING FREQUENCY + NOCTURIA Local Extension Hematogenous spread into paravertabral veins METASTATIC INVOLVEMENT OF THE SPINE Perineural invasion NEUROGENIC INCONTINENCE Urinary retention HYDRONEPHROSIS Acute Post-renal failure

HISTOLOGICAL ZONES OF THE PROSTATE Central zone This surrounds the ejaculatory ducts and is thought to derive embryologically from the Woiffian ducts, similar to the seminal vesicle.' Tumour is rare in this area. Transition zone This is the area around the prostatic urethra and is the region involved in development of benign prostatic hyperplasia. 25% of prostatic cancer originates within the transition zone. Peripheral This is the largest glandular zone and 75% of prostatic cancer arise from this area. The peripheral and transition zones are thought to derive from the urogenital sinus mesenchyme. Prostate veins drain into the paravertebral system of veins; Hence the spinal metastasis